Introduction
Although myocardial contractility is very sensitive to reductions in blood flow due to coronary artery stenosis or occlusion, the mechanisms responsible for this contractile depression are not completely understood. Factors thought to play a causal role in ischemic contractile dysfunction are (a) a decrease of Preliminary results of this study were presented at the 64th Scientific Session of the American Heart Association, Anaheim, CA, 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] No- To assess the role of cytosolic free calcium in depressing contractility during reductions of coronary flow, several investigators have measured the cytosolic free calcium transient during ischemia (1) (2) (3) (4) . However, these studies have yielded conflicting results. Lee et al. (1) , using the calcium fluorescent probe Indo-l, and Kihara et al. (2) , using the bioluminescent calcium indicator aequorin, both showed an acute increase of the calcium transient as contractility decreased during no-flow ischemia. In contrast, Wikman-Coffelt et al. (3) , also using Indo-1, reported a 21% decrease of the calcium transient during a reduction of perfusion pressure from 110 to 80 mmHg. Furthermore, Kitakaze and Marban (4) , using the fluorine magnetic resonance spectroscopy calcium indicator 5,5'-difluoro derivative of 1,2-bis-(o-aminophenoxy)ethane-NN, N',N'-tetraacetic acid (5F-BAPTA), demonstrated a > 50% decrease of the calcium transient during a 20% reduction of coronary flow. Thus, the relationship of cytosolic free calcium to contractility during reduced coronary flow remains controversial.
Other investigators have examined the roles ofintracellular acidosis and alterations of energy phosphate metabolism in depressing contractility during coronary flow reductions. Several studies have unequivocally demonstrated increases of Pi and H+ and a decrease of AGATP (5-9) after reductions of coronary flow below 50% of control. However, greater controversy exists as to the mechanism(s) underlying the fall of contractility associated with milder coronary flow reductions (i.e., 50-99% of control). In in vivo animal models, changes of energy phosphate metabolites have been demonstrated when coronary flow or perfusion pressure was reduced to 70 to 75% of control (10, 11) . Although the increase of Pi was relatively small at this level ofcoronary flow reduction, it was ofa magnitude that has been associated with marked reductions of force and an alteration of the calcium-force relationship in skinned myofiber studies ( 12, 13) . In contrast, previous perfused heart studies (6, 7, 14, 15) reported no change in energy phosphates as measured by 31P magnetic resonance spectroscopy (31P-MRS) during mild coronary flow reductions (i.e., 50-99% of 1 . Abbreviations used in this paper: ACa., cytosolic free calcium transient amplitude; dCah, diastolic calcium; F385/F454, ration of Indo-l fluorescence intensities at emission wavelengths of 385 and 454 nm; 5F-BAPTA, 5,5'-difluoro derivative of l,2-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; MPA, methylphosphonic acid; Pi, inorganic phosphate; 3'P-MRS, 3'P magnetic resonance spectroscopy. baseline flow). This would suggest that a factor(s) other than Pi and H', such as decreased intravascular pressure, mediates contractile dysfunction during mild coronary flow reductions. However, technical factors, such as an inadequate signal/noise ratio of the 3"P-MRS spectra and experimental design, may have made it difficult to measure small changes of Pi and H' . Therefore, to clarify the mechanism(s) underlying the myocardial contractile depression associated with mild reductions of coronary flow, the present study was designed to test the following hypothesis: during mild coronary flow reductions, contractile depression results from an altered relationship between cytosolic free calcium and pressure rather than by a decrease of the cytosolic free calcium transient amplitude. Additionally, parallel experiments were performed to determine whether this alteration ofthe cytosolic free calcium-pressure relationship might be due to increased Pi, H', and/or decreased intravascular pressure. Indo-1 calcium fluorescence was used as an index of cytosolic free calcium and 3"P-MRS was used to measure Pi and H' in parallel isolated rat heart experiments.
Methods
Heart perfusion and measurement offunction Male Sprague-Dawley rats (450-550 g) were heparinized using 1,000 U i.p. and anesthetized using ketamine 100 mg i.p. Hearts were then excised and immediately arrested in cold isosmotic saline containing 20 mmol/liter KCI. Isolated hearts were perfused retrograde via the aorta at a constant pressure of 71 mmHg, using a Krebs-Henseleit perfusate containing the following (mmol/liter): 118 NaCl, 6.0 KCG, 2.5 CaCI2, 25 NaHCO3, 1.2 MgSO4, 0.5 Na2EDTA, 4.0 glucose, 10.0 pyruvate, and 20 U/liter insulin. The perfusate was continuously bubbled using a 95% 02/5% CO2 gas mixture and maintained at 37°C. A compliant latex balloon attached to a Trantec pressure transducer (American Edwards Laboratories, Irvine, CA) via rigid polyethylene tubing was inserted into the left ventricle to measure pressure. Left ventricular diastolic pressure was set at 5-10 mmHg by adjusting the balloon volume. Developed pressure was recorded on a chart recorder (series 8000; Gould Electronics, Hayward, CA). Hearts were paced at 300 beats/min using two platinum tipped electrodes connected to a stimulus generator (SD-5; Grass Instrument Co., Quincy, MA). Coronary flow was measured by collecting the heart effluent. Coronary flow reductions were produced using an in-line flowmeter that controlled coronary perfusion pressure (Gilmont Instruments, Barrington, IL). In a separate series of experiments, perfusion and developed pressures were measured over a range of coronary flows (50-140% of control), using a T connection and Trantec pressure transducer placed at the level of the heart (n = 5 for 50-100%; n = 4 for 100-140%; see Fig. 1 Calcium transient determination. Cytosolic free calcium was monitored using the ratio of Indo-1 fluorescence intensities at emission wavelengths of 385 and 454 nm (F385/F454). Three factors that could affect cytosolic free calcium determination were taken into account: motion artifact; tissue inner filter effect, which is a consequence of the myoglobin oxygenation state; and changes ofheart background fluorescence, which is primarily NADH ( 16, 17) . Motion artifact was minimized by securing the fiber bundle to the heart using a nylon girdle and by monitoring two emission wavelengths that are relatively close in the fluorescence spectrum, as this minimizes differences in motion artifact at different wavelengths ( 16) . Changes in tissue filter absorption (predominantly due to myoglobin) were minimized by using emission wavelengths that have a constant absorbance relative to changes ofthe tissue oxygenation state ( 16, 17) . Changes ofNADH background fluorescence during coronary flow reductions were accounted for by measuring the NADH background fluorescence before Indo-l loading at control flow and during a flow reduction identical to that performed after Indo-l loading (see Experimental protocol below). These NADH background fluorescence values were then subtracted, using SLM software (SLM Instruments, Inc.) from the appropriate control or low flow Indo-1 fluorescence spectrum at each emission wavelength (16 Transmural studies. To rule out the possibility that Indo-l calcium fluorescence measurements at the subepicardium do not truly represent the sequelae of mild coronary flow reductions across the entire myocardium, additional experiments were performed in which Indo-I calcium fluorescence measurements were obtained from the subendocardium using the identical experimental protocol (n = 6; see Experimental protocol below). To obtain subendocardial Indo-l calcium fluorescence data, a 0.69-mm fiber bundle was passed through the left atrium and mitral valve onto the septal endocardial surface of the left ventricle adjacent to the left ventricular pressure balloon. Subendocardial data was analyzed in the same manner as subepicardial data.
NADH measurements. To confirm that changes of NADH during mild flow reductions were stable over the 10-min data acquisition periods (after 2.5-min equilibration periods; see Experimental protocol below) experiments were performed in unloaded hearts in which coronary flow was reduced to 50 and 75% ofcontrol for 12.5 min (n = 10). Control measurements of heart background fluorescence (primarily NADH) were compared with measurements taken at 2.5 and 12.5 min after a flow reduction and after a 10-min recovery period at control flow. Repeated measurements in the same heart were performed to assess the reproducibility of background fluorescence changes.
'P-MRS acquisition measurements 3`P-MRS data were acquired using a 7 Tesla horizontal 18 cm bore magnet MRI/MRS system (Nalorac Cryogenics Corp., Martinez, CA) using a custom-built probe that placed the perfused heart within a 25-mm diameter solenoid coil. Transients were collected after the application of 180 pulses every 0.1 s. A total of 1,200 transients were collected over 2 min and summed into 4K blocks. Five consecutive 2-min spectra were collected over 10-min acquisition periods, and then summed into 10-min blocks to improve the signal/noise ratio and determine Pi, PCr, and f3-ATP concentrations (ATP). To avoid subjective errors in manual frequency domain fitting of the MRS spectra, an automated fitting program using the variable projection method (19) was used to determine peak areas and chemical shifts. 
Experimental protocol
Parallel experimental protocols were used for the Indo-I calcium fluorescence and 3`P-MRS experiments. After a 30-min equilibration period, control measurements were taken of developed pressure, coronary flow, and ACa, and dCa, (after Indo-I loading) or energy phosphates. This was followed by a 12.5-min period of a coronary flow reduction (50 or 75% of control in the Indo-l protocol; 50, 65, 75, or 85% of control in the 31P-MRS protocol). No measurements were taken during the initial 2.5 min of ischemia to allow developed pressure, fluorescence intensities, and energy phosphates to equilibrate (unpublished observations from this laboratory). Data were acquired during the subsequent 10-min period. To confirm that a steady state had been reached over the 10-min acquisition period, levels of developed pressure, NADH (before Indo-l loading), ACa, and dCaj, and PCr and ATP (first and last 2 min 3P-MRS spectra) were measured at 2.5 and 12.5 min of each coronary flow reduction. 3P-MRS measurements were performed at three to five different coronary flow reductions in random order (n = 11). A 0-min recovery period followed each flow reduction, which allowed developed pressure and coronary flow to return to baseline levels. One or two coronary flow reductions were studied during the Indo-1 protocol (n = 8 at a coronary flow of 50% of control, n = 4 at a coronary flow of 75% of control), with one second fluorescence spectra acquired after the 2.5-min equilibration period and again at 12.5 min of a coronary flow reduction to confirm that there was no change of F385/F454 during the 0-min period required to obtain high signal-to-noise 3`P-MRS data. At the end of each experiment a set of control measurements were taken to confirm there were no changes from the initial control measurements.
In a separate series ofexperiments, cytosolic free calcium, coronary flow, and developed pressure were measured at superphysiological perfusion pressures (72-95 mmHg). 3"P-MRS measurements were not acquired at these elevated perfusion pressures because at the physiological control perfusion pressure (72 mmHg) the Pi concentration is already at the limits ofresolution, even with the improved signal to noise of the present 3`P-MRS studies. Therefore, a further decrease of Pi (if it exists) could not be detected at superphysiological perfusion pressures.
Statistical analyses
Values are reported as mean±SEM. Statistical analyses were performed using paired t tests, repeated measures analysis of variance, or linear regression, when indicated. Results were considered significant when P <0.05.
Results
Hemodynamics. Fig. 1 A graphically represents the relationship between coronary flow and developed pressure over a range of coronary flows from 50 to 140% of control (baseline flow = 15.1±0.6 ml/g wet wt min'). Control coronary flow was considered to be the coronary flow at the physiological perfusion pressure of 71 mmHg (23) . Fig. 1 developed pressure remained constant over the 10-min data acquisition period at coronary flow reductions down to 50% of control (Table I) . To insure data were not altered by myocardial damage or stunning, measurements were repeated under baseline conditions at the end of each experiment. These measurements showed no difference ofdeveloped pressure or coronary flow compared with initial control values.
Indo-] calcium fluorescence results. Fig. 2 shows sample Indo-1 fluorescence and left ventricular pressure tracings at coronary flows of 100 and 50% of control. F385/F454 was used as an index of the cytosolic free calcium transient. As A B shown in Table II To determine whether there is a bradykinin-sensitive component to the Indo-1 fluorescence signal, measurements were made before and during infusion with bradykinin (10-5 M). No significant difference in the Indo-1 calcium fluorescence transient amplitude or diastolic levels was observed, despite an increase ofcoronary flow (at constant coronary perfusion pressure). This suggests that bradykinin does not significantly affect the Indo-1 calcium fluorescence signal in the perfused rat heart model. This has been previously reported by another laboratory (3).
To determine the sensitivity of the Indo-1 calcium fluorescence technique for demonstrating relative changes ofcytosolic free calcium, experiments were performed in which perfusate contractility similar to the contractile depression seen with mild coronary flow reductions in these experiments.
To determine whether the response of F385 /F454 to mild coronary flow reductions is similar at the subepicardium and subendocardium, a set of parallel Indo-1 calcium fluorescence experiments were performed on the left ventricular septal endocardial surface. At coronary flow reductions to 50% of control, no significant change in the amplitude (95±3% ofcontrol) or diastolic level (100±1% of control) of F385/F454 was observed. These data suggest that during mild coronary flow reductions to 50% of control there is no change of cytosolic free calcium at the subepicardium or subendocardium.
Experiments were also performed to assess the severity and stability ofNADH background fluorescence changes after mild coronary flow reductions after equilibration ofdeveloped pressure and metabolic parameters. After coronary flow reductions to 75% of control, NADH background fluorescence did not significantly change compared with initial control levels over the 10-min data acquisition period at steady state. However, after coronary flow reductions to 50% ofcontrol, NADH background fluorescence increased 6±1% at 2.5 min and 6±1% at 12.5 min of reduced flow compared with initial control values (Table I) . Thus, changes of NADH background fluorescence during mild coronary flow reductions remained constant over the 10-min data acquisition period after a 2.5-min equilibration period. Multiple flow reductions to 50% ofcontrol flow in the same heart demonstrated these increases in background fluorescence to be reproducible. Control NADH background fluorescence levels after a 0-min recovery period were identical to initial control levels.
3"P-MRS results. Analysis of the five consecutive 2-min spectra acquired at each coronary flow reduction demonstrated that PCr and ATP remained constant over the 10-min data acquisition periods, confirming that at each flow reduction a steady state had been achieved (Table I) . Pi was not quantitated using 2-min spectra due to insufficient signal/noise. Mea- 4 ,mol/ g dry wt, as is usually seen during prolonged isolated heart perfusions (6). The nonspecificity of this change over time relative to the present protocol was confirmed by studying hearts at control coronary flow (n = 2) over a time course similar to that in the above experiments. A comparable decrease was noted in ATP, whereas Pi and PCr remained constant. signal/noise ratio attained using our coil and experimental protocol, as well as the small, but consistent increase in Pi that was observed during mild coronary flow reductions. Table II shows the pooled 3MP-MRS data from the 10-min summed spectra. Fig. 4 a shows that Pi increased as coronary flow was reduced, with a significant rise of Pi observed when coronary flow was reduced to 75% of control, from 2.5±0.3 to 4.2±0.4
gmol/g dry wt. In contrast, pH did not significantly decrease until coronary flow was reduced 50%, from 7.11±0.01 to 7.07±0.01 (Fig. 4 b) . PCr did not significantly decrease until coronary flow was reduced to 50% ofcontrol, from 41.6±1.3 to 38.1±1.5 imol/g dry wt (Fig. 4 c) , and ATP was unchanged over the range of coronary flow reductions studied (Fig. 4 d) .
As shown in (Fig. 6 a) . AGATp also demonstrated a linear relationship with coronary flow from -60.9±0.3 to -57.6±0.3 kJ/mol (Fig. 6 b) .
To determine whether the increased Pi was secondary to changes in energy phosphate metabolism resulting from ischemia versus an increase of unbound or NMR "visible" Pi (20, 24) , energy phosphates (PCr, ATP, Pi) were summed at baseline and coronary flow reductions. Although no significant change in total phosphate metabolites could be demonstrated, Table II shows an increasing trend with coronary flow reductions.
Discussion
The major findings ofthis study were (a) during mild coronary flow reductions the cytosolic free calcium transient amplitude (4) , using the fluorine magnetic resonance spectroscopy calcium indicator 5F-BAPTA, demonstrated a decrease of ACa1 of> 50% after a reduction of coronary perfusion pressure from 80 to 60 mmHg (coronary flow reduced to -80% of control). However, their experimental conditions were very different from those of the present study.
A perfusate calcium concentration of 8 mM was used to partially compensate for the calcium buffering effect of 5F-BAPTA. Increasing perfusate calcium in the presence of 5F-BAPTA results in developed pressures of -20-40 mmHg and produces end diastolic pressures of40-60 mmHg (unpublished data from this laboratory). Furthermore, Kitakaze and Marban (4) observed a > 50% reduction of developed pressure when perfusion pressure was reduced by 25% compared with a fall ofdeveloped pressure of < 25% in hearts not perfused with 5F-BAPTA. This suggest that hearts loaded with 5F-BAPTA in the presence of high perfusate calcium may have an altered relationship between perfusion pressure and contractility. Finally, Kitakaze and Marban (4) used a reduced pacing rate of 1 Hz and a reduced perfusate temperature of 30'C. Therefore, differences between the present study and previous studies are most likely due to differences in experimental design and methodology. Although no isolated perfused heart model can be considered truly physiological, the present study was designed to more closely mimic in vivo conditions (23) .
A major criticism of cytosolic free calcium measurements obtained by Indo-l calcium fluorescence in perfused hearts has been that data is obtained at the epicardial surface and, therefore, does not truly reflect transmural cytosolic free calcium levels after ischemic interventions. Transmural gradients ofcoronary flow and microvascular pressures have been demonstrated in porcine and canine hearts under normal physiological conditions and during low flow ischemia (25) (26) (27) . However, significant differences in relative coronary flow or microvascular pressure in the endocardium compared with the epicardium did not occur with milder reductions in coronary perfusion pressure, only at more severe reductions. In the present study, parallel experiments performed at the endocardial and epicardial surfaces during coronary flow reductions to 50% of control demonstrated no significant change in the cytosolic free calcium transient amplitude or diastolic level. Therefore, the present observations at both the epicardium and endocardium most likely reflect cytosolic free calcium levels throughout the myocardium and suggest that myocardial contractility is not regulated by a decrease ofthe cytosolic free calcium transient during mild reductions of coronary flow.
Potential mediators ofcontractile depression Inorganic phosphate. The observed increases of Pi during mild coronary flow reductions (Fig. 4 a) (8) showed a relationship between decreases in coronary perfusion pressure and a fall of PCr/Pi in the perfused rat heart. However, several perfused heart studies have suggested that the fall in contractility associated with mild coronary flow reductions occurs without changes in cardiac energy phosphates (6, 7, 14, 15 The present study, which demonstrates a significant increase of Pi at a coronary flow to 75% of control, differs in several ways from the aforementioned reports. The signal/ noise ratio of the 3"P-MRS spectra was substantially improved by acquiring data over 10-min steady state periods of mild coronary flow reductions. The experimental protocol allowed for data acquisition at several coronary flow reductions produced in a random order, without the need to first produce "no-flow" ischemia, as was done in a previous study (6) . Furthermore, coronary flow was returned to baseline between each flow reduction period. This prevented the possible complications of myocardial stunning or injury, as evidenced by the return of energy phosphate metabolites and mechanical function to baseline between interventions and at the end of each experiment. In addition, in the present study, other factors such as substrates, pacing rate, and coronary perfusion pressure more closely mimicked in vivo physiological conditions (23 Kentish ( 12) , who demonstrated that increases of Pi caused a fall ofcontractile force in skinned myofibers. Kentish ( 12) Intravascular pressure. Another proposed mediator ofcontractile depression during mild coronary flow reductions is decreased intravascular pressure. The importance of the role of changes in intravascular pressure, the "garden hose" effect, in contractile depression during mild underperfusion remains controversial (28, 29) . Some studies suggest that vascular collapse may be an important mediator of contractile depression after acute no-flow ischemia (29, 30) . However, other studies have demonstrated a close relationship between the initial fall of pressure and energy phosphate metabolites after acute noflow ischemia, suggesting that vascular collapse is not important in mediating contractile depression (31, 32) .
In the present study, although the role ofdecreased intravascular pressure was not directly examined, elevations of perfusion pressure > 71 mmHg increased developed pressure further, without a change of cytosolic free calcium levels. This suggests that increased intravascular pressure may be an important mediator of the further increases ofcontractile force at higher perfusion pressures. Because of signal-to-noise resolution limitations, Pi could not be assessed at these superphysiological pressures to determine iffurther decreases might occur.
Nevertheless, the finding ofincreased developed pressure at superphysiological perfusion pressures is consistent with the view that decreases in intravascular pressure during coronary flow reductions, as well as increased Pi, may play a role in mediating the contractile dysfunction through an alteration of the relationship between cytosolic free calcium and contractile force. Further studies will be necessary to determine the relative importance of vascular pressure as a mediator of contractile failure during graded reductions of coronary flow.
Intracellular acidosis. Intracellular acidosis has been considered another potential mediator of contractile depression during mild coronary flow reductions. The results of the present study are in agreement with the previous findings of Jacobus et al. (5) , who also reported no change of intracellular pH until coronary flow was reduced to 50% of control. Additionally, other studies have demonstrated significant increases in lactate only when coronary flow was reduced below 50% of control (8, 15) . Taken together with those ofthe present study, these data suggest that intracellular acidosis does not play a significant role in the contractile depression associated with mild coronary flow reductions.
Conclusion
The cytosolic free calcium transient amplitude did not decrease during mild reductions of coronary flow. These data support the hypothesis that during mild coronary flow reductions contractility is depressed by an alteration of the relationship between cytosolic free calcium and pressure, rather than by a decrease of the cytosolic free calcium transient. Furthermore, increased Pi and decreased intravascular pressure may mediate this contractile depression by altering the cytosolic free calcium-pressure relationship. Intracellular acidosis does not appear to play a role in depressing contractility during mild coronary flow reductions.
